Menta Capital’s AtriCure ATRC Stock Holding History

Menta Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,300	Closed	-$276K	–	490
2019 Q1	$276K	Buy	10,300 +300	+3%	+$9.11K	0.12%	300
2018 Q4	$306K	Buy	10,000 +3,900	+64%	+$121K	0.11%	301
2018 Q3	$214K	Buy	+6,100	New	+$193K	0.07%	469
2017 Q4	–	Sell	-39,644	Closed	-$887K	–	633
2017 Q3	$887K	Buy	+39,644	New	+$896K	0.13%	283
2014 Q1	–	Sell	-12,426	Closed	-$232K	–	383
2013 Q4	$232K	Sell	12,426 -12,900	-51%	-$188K	0.1%	277
2013 Q3	$278K	Buy	25,326 +2,800	+12%	+$27.6K	0.14%	236
2013 Q2	$214K	Buy	+22,526	New	+$196K	0.14%	306

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Menta Capital's ATRC Position: Q2 2019 in Review

Menta Capital sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 10,300 shares — an estimated $276K sold.

Menta Capital first reported a position in ATRC in Q2 2013 and held it in 7 quarters. The position peaked at $887K in Q3 2017. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

Menta Capital reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
Menta Capital sold 10,300 AtriCure shares in Q2 2019, an estimated $276K.
Menta Capital first reported a position in AtriCure in Q2 2013 and held it in 7 quarters.
Menta Capital's AtriCure position peaked at $887K in Q3 2017.
145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.